文献速递肾癌与肾肿瘤

高风险疾病与随访不佳:退伍军人队列中肾肿块活检的重要性

High-risk Disease and Poor Follow-up: The Importance of Renal Mass Biopsy in a Cohort of Veterans.
PubMed 文献 · Urology · 2022-05-16

该质量改进分析纳入2015年6月至2020年11月间130例患者的136次肾肿块活检,评估其临床效用。全组诊断率94.1%(128/136),T1a肾肿块诊断率94.1%(95/101),并发症率2.2%。实性T1a肿块中意外侵袭性病变占8/89(9.0%),主动监测组与治疗组对NCCN推荐影像随访的依从率分别为50%和47%。

要点

  • 肾肿块活检全组诊断率94.1%(128/136),T1a肾肿块诊断率94.1%(95/101)。
  • 实性T1a肿块中意外侵袭性病变(Fuhrman 4级、2型乳头状或肉瘤样特征)占8/89(9.0%)。
  • 主动监测组与治疗组对NCCN推荐影像随访的依从率分别为50%和47%。

核心结论

  • 在该退伍军人队列中,高风险病变发生率显著且随访影像依从性差。
  • 鉴于9%的小肾肿块高度侵袭性,活检可能对选择主动监测候选者至关重要。
  • 作者认为,采用积极活检方案并高度考虑治疗可能适合限制失访者的风险。

研究设计与样本

  • 该研究为质量改进分析,纳入2015年6月至2020年11月间130例患者的136次肾肿块活检。
  • 分析内容包括人口统计学、肿块大小、病理、治疗及活检并发症。
  • 101个T1a肿块中,89个为诊断性或非复杂性囊肿,77个符合随访影像依从性分析纳入标准。

主要发现

  • 中位年龄66岁。
  • 全组诊断率94.1%(128/136),T1a肾肿块诊断率94.1%(95/101),并发症率2.2%。
  • 实性T1a肿块中意外侵袭性病变(Fuhrman 4级、2型乳头状或肉瘤样特征)为8/89(9.0%)。
  • 57例(64%)患者接受冷冻消融或手术,32例(36%)患者选择主动监测。
  • 选择主动监测的患者中16例(50%)有肿瘤性发现(嗜酸细胞瘤或肾细胞癌),选择治疗的患者中52例(91%)有肿瘤性发现。

临床怎么用

  • 作者认为,鉴于9%的小肾肿块高度侵袭性,活检可能对选择主动监测候选者至关重要。
  • 作者认为,采用积极活检方案并高度考虑治疗可能适合限制失访者的风险。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the clinical utility of renal mass biopsy (RMB) in our multistate system. RMB is useful in the management of masses ≤4 cm (T1a), but evaluation of RMB in the uniquely vulnerable Veteran population is lacking. METHODS: About 136 RMB in 130 patients performed between 06/2015 and 11/2020 were identified in this Quality Improvement analysis. Demographics, size, pathology, treatment, and biopsy complications were analyzed. Of 101 T1a masses, 89 were either diagnostic or not decompressed cysts and 77 met inclusion criteria for follow-up imaging compliance analysis. RESULTS: The median age was 66 years. The diagnostic rate was 94.1% (128/136) for all masses and 94.1% (95/101) for T1a renal masses, with a complication rate of 2.2%. Among solid T1a masses, unexpectedly aggressive lesions (Fuhrman Grade 4, Type 2 papillary or sarcomatoid features) were identified in 8/89 (9.0%). Fifty-seven (64%) patients were treated with cryoablation or surgery and 32 (36%) patients elected active surveillance (AS). A neoplastic finding (oncocytoma or renal cell carcinoma (RCC)) was present in 16 patients choosing AS (50%) compared to 52 patients choosing treatment (91%). Compliance with National Comprehensive Cancer Network-recommended imaging was 50% and 47% for AS and treatment groups, respectively. CONCLUSION: In this VA cohort, we found a significant incidence of high-risk lesions and poor compliance with follow-up imaging. Aggressive biopsy protocols with high consideration of treatment may be appropriate to limit risk in those lost to follow-up. Given that 9% of our small renal masses were highly aggressive, biopsy may be critical in the selection of AS candidates.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Anishchenko K, Antoine S, Geiger C, et al. High-risk Disease and Poor Follow-up: The Importance of Renal Mass Biopsy in a Cohort of Veterans. Urology. 2022. PMID: 35588788. doi:10.1016/j.urology.2022.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。